Nymox Pharmaceutical Corp P/L
Qual é o P/L de Nymox Pharmaceutical Corp?
O P/L de Nymox Pharmaceutical Corp é 0.00
Qual é a definição de P/L?
A razão entre preço e lucro é a razão entre o preço das ações de uma empresa e o lucro por ação da empresa, calculado ao longo de doze meses.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/L de empresas na Setor Health Care em NASDAQ em comparação com Nymox Pharmaceutical Corp
O que Nymox Pharmaceutical Corp faz?
nymox pharmaceutical corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. its lead drug candidate is fexapotide triflutate (nx-1207) that has completed phase iii clinical trials for the treatment of benign prostatic hyperplasia; and is in phase ii clinical trial for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. the company also develops and markets nicalert and tobacalert test strips that use urine or saliva to detect use of tobacco products. in addition, it offers alzheimalert, a proprietary urine assay that aids physicians in the diagnosis of alzheimer's disease. the company operates in canada, the united states, europe, and internationally. nymox pharmaceutical corporation was founded in 1989 and is headquartered in nassau, bahamas.
Empresas com p/l semelhantes a Nymox Pharmaceutical Corp
- Richland Resources International tem P/L de N/A
- Safeplus International tem P/L de N/A
- China Yanyuan Yuhui Natl Ed Grp tem P/L de N/A
- Acusphere tem P/L de N/A
- American Oriental Bioengineering tem P/L de N/A
- Gourmet Provisions International tem P/L de N/A
- Nymox Pharmaceutical Corp tem P/L de 0.00
- SEL Manufacturing tem P/L de 0.00
- China Zhong Qi Hldgs tem P/L de 0.00
- MedSmart tem P/L de 0.00
- Panbela Therapeutics tem P/L de 0.00
- Epic tem P/L de 0.00
- 2574 tem P/L de 0.00